These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 10694813

  • 1. Inhibition of HIV-1 replication in chronically infected cell lines and peripheral blood mononuclear cells by retrovirus-mediated antitat gene transfer.
    Li Y, Starr SE, Lisziewicz J, Ho WZ.
    Gene Ther; 2000 Feb; 7(4):321-8. PubMed ID: 10694813
    [Abstract] [Full Text] [Related]

  • 2. Antitat gene therapy: a candidate for late-stage AIDS patients.
    Lisziewicz J, Sun D, Lisziewicz A, Gallo RC.
    Gene Ther; 1995 May; 2(3):218-22. PubMed ID: 7614253
    [Abstract] [Full Text] [Related]

  • 3. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
    Popik W, Pitha PM.
    Virology; 1994 Aug 01; 202(2):521-9. PubMed ID: 8030218
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1.
    Chang HK, Gendelman R, Lisziewicz J, Gallo RC, Ensoli B.
    Gene Ther; 1994 May 01; 1(3):208-16. PubMed ID: 7584083
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapy.
    Lisziewicz J, Sun D, Trapnell B, Thomson M, Chang HK, Ensoli B, Peng B.
    J Virol; 1995 Jan 01; 69(1):206-12. PubMed ID: 7983711
    [Abstract] [Full Text] [Related]

  • 12. Rapid protection against human immunodeficiency virus type 1 (HIV-1) replication mediated by high efficiency non-retroviral delivery of genes interfering with HIV-1 tat and gag.
    Lori F, Lisziewicz J, Smythe J, Cara A, Bunnag TA, Curiel D, Gallo RC.
    Gene Ther; 1994 Jan 01; 1(1):27-31. PubMed ID: 7584056
    [Abstract] [Full Text] [Related]

  • 13. Limitation of Tat-associated transcriptional processivity in HIV-infected PBMC.
    Adams M, Wong C, Wang D, Romeo J.
    Virology; 1999 May 10; 257(2):397-405. PubMed ID: 10329550
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Natural killer cell inhibits human immunodeficiency virus replication in chronically infected immune cells.
    Zhang T, Li Y, Wang YJ, Wang X, Young M, Douglas SD, Ho WZ.
    Antiviral Res; 2007 Feb 10; 73(2):132-9. PubMed ID: 16997390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.